Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forza: Formoterol-beclomethasone in bronchiectasis
2017-001665-25Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bronchiectasis comparing Foster with Placebo (2 arms). Primary endpoint: Leicester Cough Questionnaire score. Started Jul 2018; status: active.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2017-001665-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001665-25.